In 2013, Heneka, M.T. et al. published a paper titled “NLRP3 inflammasome is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice” in Nature, confirming the association between NLRP3 and AD pathogenesis. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.